Alzheimer’s disease is one of the most common causes of memory loss and dementia in older adults.
It slowly damages the brain, affecting thinking, memory, and daily functioning. For many years, scientists have been trying to find treatments that can slow down or stop the disease, but progress has been slow.
In recent years, a new type of medicine called monoclonal antibodies has shown some promise. These drugs work by reducing levels of a harmful protein called amyloid in the brain. Amyloid builds up and forms sticky clumps known as plaques, which are believed to damage brain cells over time.
While these treatments can slow the disease slightly, they require frequent hospital visits for infusions, often once or twice a month, and can be difficult for patients to manage.
Now, a new study published on March 5 in the journal Science offers a very different approach. Researchers at Washington University School of Medicine in St. Louis have developed an experimental therapy that may only need a single injection. This new method uses specially engineered brain cells to help clear harmful proteins from the brain.
The idea behind this therapy comes from a type of cancer treatment known as CAR-T cell therapy. In cancer care, doctors modify immune cells so they can find and destroy cancer cells more effectively. Inspired by this approach, scientists in this study decided to modify a different type of cell found in the brain.
Instead of using immune cells, the researchers focused on astrocytes. Astrocytes are one of the most common types of cells in the brain. Normally, they help support neurons, maintain balance in the brain, and keep the environment healthy. In this study, scientists changed astrocytes so they could actively remove harmful amyloid proteins.
To do this, they introduced a special gene into astrocytes using a harmless virus. This gene allowed the cells to produce a structure called a chimeric antigen receptor, or CAR. This receptor acts like a sensor, helping the astrocytes find and attach to amyloid proteins. Once attached, the cells can swallow and break down these harmful substances.
The results in animal studies were very promising. In mice that were genetically likely to develop Alzheimer’s disease, the treatment had strong effects.
When the therapy was given early, before amyloid plaques had formed, it completely prevented the buildup of plaques in the brain. This is important because stopping plaque formation early could potentially delay or prevent the disease from developing.
The researchers also tested the therapy in mice that already had large amounts of amyloid plaques in their brains. In these cases, the treatment still worked well. It reduced the amount of amyloid by about 50 percent compared to untreated mice. This suggests that the therapy may not only prevent the disease but also help treat it after it has already started.
To understand why this approach is important, it helps to know how the brain normally deals with waste. The brain has its own immune cells called microglia, which act like cleaners.
They remove waste and harmful materials. However, in diseases like Alzheimer’s, these cells can become overwhelmed and stop working properly. As a result, amyloid builds up and damages brain cells.
By turning astrocytes into additional cleaning cells, the researchers created a new system to support the brain. These engineered cells can take on part of the cleaning work and help reduce the burden on microglia.
Another important advantage of this therapy is convenience. Unlike current treatments that require repeated infusions, this approach may only need a single injection. This could make treatment much easier for patients and reduce the burden on healthcare systems.
However, it is important to note that this research is still in early stages. The experiments were done in mice, not in humans. More studies are needed to make sure the therapy is safe and effective in people. Scientists also need to ensure that the modified cells do not harm normal brain function.
The researchers are continuing to improve the therapy. They are working to make the targeting more precise and to reduce the risk of side effects. They are also exploring whether this technology can be used for other brain diseases.
One exciting possibility is using similar engineered cells to treat brain tumors. By changing what the CAR receptor recognizes, scientists may be able to direct these cells to attack cancer cells instead of amyloid plaques.
Overall, this study offers a new way of thinking about Alzheimer’s treatment. Instead of relying only on drugs, it shows that reprogramming the body’s own cells could be a powerful strategy. While it will take time before this therapy is ready for patients, the findings provide hope for more effective and easier treatments in the future.
In conclusion, this research represents an important step forward in the fight against Alzheimer’s disease. It suggests that a single treatment could potentially prevent or reduce the buildup of harmful proteins in the brain.
At the same time, careful testing is still needed to confirm its safety and long-term effects. If successful, this approach could change how Alzheimer’s and other brain diseases are treated in the years to come.
If you care about Alzheimer’s disease, please read studies about vitamin D deficiency linked to Alzheimer’s and dementia, and strawberries can be good defence against Alzheimer’s.
For more health information, please see recent studies about foods that reduce Alzheimer’s risk, and oral cannabis extract may help reduce Alzheimer’s symptoms.
Copyright © 2026 Knowridge Science Report. All rights reserved.
